SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-341169
Filing Date
2018-12-03
Accepted
2018-12-03 16:36:30
Documents
52
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d645011d10q.htm 10-Q 865455
2 EX-31.1 d645011dex311.htm EX-31.1 9551
3 EX-31.2 d645011dex312.htm EX-31.2 9552
4 EX-32.1 d645011dex321.htm EX-32.1 5137
  Complete submission text file 0001193125-18-341169.txt   2997022

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT logc-20180930.xml EX-101.INS 391219
6 XBRL TAXONOMY EXTENSION SCHEMA logc-20180930.xsd EX-101.SCH 33401
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE logc-20180930_cal.xml EX-101.CAL 41152
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE logc-20180930_def.xml EX-101.DEF 199746
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20180930_lab.xml EX-101.LAB 252870
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20180930_pre.xml EX-101.PRE 234453
Mailing Address 700 MAIN STREET CAMBRIDGE MA 02139
Business Address 700 MAIN STREET CAMBRIDGE MA 02139 61(0)428-338-594
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38707 | Film No.: 181214386
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1